Rebecca Gonzalez

Statistics

Publications

Citations

448

H-Index

Active since

2015

Affiliations

Moffitt Cancer Center(Current)

Stanford University

Medical University of South Carolina

Huntsman Cancer Institute

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Rebecca Gonzalez is an author at Moffitt Cancer Center specializing in multiple myeloma treatment, refractory multiple myeloma, and clinical immunology.

ORCID

Publications per year

2015–2023

Publications

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 279 citations · Full text

Medicine, Immunology, Oncology +15

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi et al. · Blood Advances · 2022 · 99 citations · Full text

Medicine, Hematology, Oncology +14

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment

Surbhi Sidana, Lauren C. Peres, Hamza Hashmi et al. · Haematologica · 2023 · 41 citations · Full text

Medicine, Immunology, Nephrology +15

Clotrimazole troches induce supratherapeutic blood levels of sirolimus and tacrolimus in an allogeneic hematopoietic cell-transplant recipient resulting in acute kidney injury

Jessica El‐Asmar, Rebecca Gonzalez, Ryan Bookout et al. · Hematology/Oncology and Stem Cell Therapy · 2015 · 17 citations · Full text

Pharmacy, Hematology, Pharmacology +17

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

Aleksandr Lazaryan, Stephanie J. Lee, Mukta Arora et al. · Blood Advances · 2021 · 12 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +12

1–5 of 5